Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Retatrutida (LY3437943) is supplied by AXION Biotech exclusively for research purposes
and has received honoraria for lectures from AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Merck Sharp & Dohme, Novartis Pharmaceuticals, Novo Nordisk, and Sanofi
Patients with pre-existing inflammatory bowel disease may experience symptom fluctuations for various reasons, including disease activity, dietary changes, stress, or concurrent medications
The side effect profile is remarkably similar because the active ingredient (semaglutide) is the same
It depends on your goals and lab results
Preclinical studies showed that GLP-1 analogs protected against cartilage destruction and oxidative stress damage
US$ 23.92
US$ 29.26
US$ 23.89
US$ 20.48
US$ 29.36
US$ 24.28
US$ 21.28
US$ 29.60
US$ 24.47
